Next Article in Journal
Compositing Benzothieno[3,2-b]Benzofuran Derivatives with Single-Walled Carbon Nanotubes for Enhanced Thermoelectric Performance
Previous Article in Journal
Functional Characterization and Anti-Tumor Effect of a Novel Group II Secreted Phospholipase A2 from Snake Venom of Saudi Cerastes cerates gasperetti
Previous Article in Special Issue
Pseudomonas PA14H7: Identification and Quantification of the 7-Hydroxytropolone Iron Complex as an Active Metabolite against Dickeya, the Causal Agent of Blackleg on the Potato Plant
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Kinetic Study on the Base-Catalyzed Imine-Enamine Tautomerism of a Chiral Biologically Active Isoxazoline Derivative by HPLC on Amylose Tris(3,5-dimethylphenylcarbamate) Chiral Stationary Phase

1
Centre for the Control and Evaluation of Medicines, Chemical Medicines Unit, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
2
Department of Drug Chemistry and Technologies, Sapienza University of Rome, 00185 Rome, Italy
3
Department of Pharmacy, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy
*
Author to whom correspondence should be addressed.
Molecules 2023, 28(18), 6518; https://doi.org/10.3390/molecules28186518
Submission received: 1 August 2023 / Revised: 28 August 2023 / Accepted: 29 August 2023 / Published: 8 September 2023
(This article belongs to the Special Issue Chemical Analysis of Bioactive Compounds)

Abstract

:
Isoxazoline is a nitrogen- and oxygen-containing five-membered heterocyclic scaffold with diverse biological profiles such as antimicrobial, fungicidal, anticancer, antiviral, analgesic and anti-inflammatory activity. Accordingly, the use of this peculiar structural framework in drug discovery is a successful strategy for the development of new drug candidates. Here, a chiral saccharin/isoxazoline hybrid was considered to investigate the tendency of the imine moiety of the heterocyclic ring to tautomerize to the enamine form in the presence of a basic catalyst. The pseudo-first-order rate constants for the base-catalyzed tautomerization process were measured in different solvents and at different temperatures by off-column kinetic experiments based on the amylose (3,5-dimethylphenylcarbamate)-type chiral stationary phase. The kinetic results obtained in this study may be a useful aid in the perspective of designing experimental conditions to control the stereointegrity of these types of pharmacologically active compounds and drive their synthesis toward the preferred, imine or enamine, tautomer.

1. Introduction

High-performance liquid chromatography (HPLC) on chiral stationary phase (CSP) is an effective and direct enantioseparation technique. It is widely used on a laboratory and industrial scale to determine the enantiomeric excess (ee) of natural and synthetic chiral compounds, including enantiopure drugs, and to isolate enantiopure forms on a semi-preparative and preparative scale [1].
The general mechanism of chiral discrimination is based on the transient formation of diastereomeric adducts between each enantiomer of the chiral sample to be chromatographed (the selectand) and the chiral structure bound to the chromatographic support (the selector).
At the microscopic level, enantioseparation can be achieved when a pair of resolvable enantiomers exploit enantiospecific differences in interaction with the active sites of a chiral selector. The thermodynamic driving force that enables enantioseparation is the energy difference between two transient diastereomeric enantiomers/CSP complexes (ΔΔG°). Typically, the range of interest for HPLC applications requires the performance of discriminations characterized by ΔΔG° values greater than 0.11 kcal mol−1, an amount of energy that, according to the following equation, ΔΔG° = −RT × ln(α), corresponds to enantioseparation factor (α) values greater than 1.2. The intermolecular interactions controlling the energy of the diastereomeric complexes are both attractive and repulsive, e.g., H-bonds, dipole-dipole, van der Waals, π-π, ionic and steric interactions [2]. However, it must be emphasized that even if the chiral recognition process on a given CSP is thermodynamically favored, it may be hampered or precluded by the establishment of competitive on-column secondary dynamic processes involving the enantiomers and occurring on the time scale necessary to achieve the desired resolution [3,4,5,6]. The existence of such equilibria leads to the production of de novo species and therefore to potential peak splitting, which, in turn, if the competitive process proceeds at a rate similar to that of the separation process, will also be characterized by the presence of plateau zones between interconverting species. Such aberrations of the chromatographic profile are considered an obstacle to separation, but in other types of studies, such as those performed by dynamic HPLC, they may be indicative of the stereochemical lability of the analyte and may be used to determine the energy barrier of the competitive process [7,8,9].
The enantiomerization of stereolable enantiomers [3,7,8,9] and the tautomerization of keto-enols [10,11] and imine-enamines [12] are well-established dynamic on-column processes, which, in the first, case refer to the inversion of the absolute configuration of a chiral analyte and, in the second case, to an equilibrium between two tautomeric species, both occurring on the separation time scale.
Thus, as a function of the chosen experimental HPLC conditions, the primary distribution equilibria between CSP and the mobile phase and the secondary equilibria can compete with each other and, depending on which of them is the dominant process, allow or suppress the observed separation. The instability of enantiomers or isomers is a topic of interest for academia and pharmaceutical companies when the species affected by the phenomenon of interconversion is a biologically active compound. In this regard, since 1993, drug regulatory authorities have considered it mandatory to provide comprehensive information on the stereochemical stability of those drugs that are administered as individual enantiomers or isomers [13].
It is therefore necessary to study the kinetics of configurational interconversion and the factors that influence the stability of the individual stereoisomers of biologically active molecules.
From this perspective, the aim of this work is to study the configurational stability of compound 1 (Figure 1), chosen as a representative of a class of saccharin-isoxazoline derivatives. The choice of this chemical class was based on two aspects. First, the isoxazoline derivatives are characterized by important pharmacological activities such as antimicrobial, anti-inflammatory, antiviral, analgesic, antithrombotic and antitumor activities; therefore, they could be chosen as an important basic scaffold in the development of new pharmaceutical compounds [14]. Second, isoxazolines are widely used as advanced intermediates in the synthetic process of bioactive compounds due to their high chemical stability and hydrogen bonding ability. In particular, compound 1 (Figure 1) has shown an interesting inhibitory and selective activity toward enzymatic isoforms CAIX and CAXII of carbonic anhydrase (CA). Due to this peculiar biological activity, some analogs of 1 are candidates as antitumor agents [15].
As shown in Figure 1, two critical fragments of the isoxazoline cycle are potentially of interest for stereoisomerization, namely the C5 stereogenic center and the unconjugated imine double bond.
Enantiomers of saccharine-isoxazoline derivatives have shown a high enough stereochemical stability to allow their chromatographic separation at room temperature [15]. On the other hand, the tendency of isomerization of the imine moiety into the enamine form, which is an important structural element for biological activity, remains to be evaluated.
In this work, the kinetic parameters of the base-catalyzed imine-enamine interconversion of 1 (Figure 1) were determined by a classical batchwise operational approach combined with enantio- and tautomer-selective HPLC. The amylose-based Chiralpak IA was chosen as the chiral stationary phase. Kinetic studies were carried out in some organic protic and aprotic solvents containing a basic catalyst and at different temperatures.

2. Results

2.1. Base-Catalyzed Imino-Enamine Tautomerism Studied by HPLC on Chiral Stationary Phase

The first step of our study was to evaluate the chiral recognition ability of the amylose (3,5-dimethylphenylcarbamate)-based Chiralpak IA column under polar organic conditions. The amylose derivative is considered one of the most effective chiral selectors for achieving chiral resolution [16,17,18].
A baseline separation of the enantiomers of 1 was achieved using pure methanol as a mobile phase. As can be seen in Figure 2a, the profile of the chromatogram did not show the typical deformation resulting from on-column secondary configurational interconversion processes [3,4,5,7,8,9].
This indicates that the compound was configurationally stable under the conditions and analysis times employed for chromatographic separation. Conversely, a dramatic change in the elution profile of the isoxazoline derivative was observed when a basic species, such as diethylamine (DEA), was added to the alcoholic mobile phase (Figure 2b).
It is possible to observe how, at a temperature of 10 °C, using the mixture methanol:DEA 100:0.6 (v/v) as a mobile phase, a new chemical species was clearly visible, eluted before the imine enantiomeric peaks (1i) and connected to them by a plateau region. The height of the plateau gradually increased by gradually increasing the temperature of the chromatography column up to 40 °C. The generated plateau zone was formed by the chemical species that underwent the secondary process of interconversion at least once during the chromatographic separation; the initial and terminal peaks instead corresponded to the molecules that maintain their configuration throughout the resolution process.
Looking at the chromatogram detected by monitoring the sign of CD at 263 nm during chromatography (Figure 2b), it is interesting to note that, at 40 °C, the peak corresponding to the novo chemical species split into a pair of bisegnated peaks. This indicates that the species resulting from the dynamic interconversion process were chiral.
From this evidence, it is possible to hypothesize that the dynamic process is a base-catalyzed imine–enamine (I⇆E) tautomerization. The base-catalyzed imine-enamine tautomerization involves two steps (Figure 1): the removal of a proton from the base to form a resonance-stabilized carbanion and the subsequent transfer of the proton, which can bind to the starting carbon or nitrogen.
To verify this hypothesis and to quantitatively evaluate the configurational stability of the isooxazoline compound, a series of off-column kinetic experiments were performed. Samples of 1 in enantiomeric or racemic forms were incubated at the desired temperature in a suitable reaction solvent containing triethylamine (TEA) as a basic catalyst. At recorded time intervals, the chiral samples were analyzed by HPLC on the Chiralpak IA CSP in stereoselective conditions that quenched the interconversion (mobile phase: ethanol-ethyl acetate-DEA 100:20:0.1 (v/v/v); column temperature: 25 °C; flow rate: 0.8 mL/min). Under these conditions, the competitive on-column base-catalyzed tautomerism did not occur on the time scale of the chromatographic separation, as indicated by the absence of plateau-like regions between two well-resolved peak pairs (Figure 3).
As shown in Figure 3, the areas of the third and fourth eluted peaks, corresponding to the imine form of 1 (1i), decreased; at the same time, two enantiomeric peaks, corresponding to the enamine form (1e), appeared, and their areas progressively increased over the isomerization reaction time. Thus, the isomeric ratio (calculated at the isosbestic point; see Figure S1 in the Supplementary Materials) changed progressively with time and, at equilibrium, the tautomeric enamine form was the most stable (64.5%). The evaluation of the signs and areas of the peaks obtained by online circular dichroism (CD) measurements was the empirical tool to track the isomerization process. The peaks in enantiomeric relationships were easily identifiable because they had the same area but opposite signs. Therefore, (i) each chromatogram showed two pairs of peaks corresponding to four stereoisomers, and (ii) each pair of peaks with the same area and opposite CD sign was in an enantiomeric relationship.
By repeating the same kinetic experiment but replacing the racemic mixture with the enantiopure (S)-3i, it was possible to demonstrate that the conversion of the imine into the enamine form proceeded without concomitant racemization. In fact, the absence in the chromatographic patterns of the peaks corresponding to the isomers (R)-1e and (R)-1i excluded the simultaneous stereochemical inversion at the stereocenter C5 of the heterocyclic moiety (Figure 4).
Since the isomerization reaction did not involve cleavage of any of the bonds of the stereogenic center, (S)-1i, corresponding to the fourth peak, produced the first eluting isomer (S)-1e, and consequently the second and third eluting isomers shared the R configuration. The resulting isomeric elution order on the Chiralpak IA CSP was as follows (S)-1e < (R)-1e < (R)-1i < (S)-1i. The peaks pertinent to the (S)-1e/(S)-1i and (R)-1e/(R)-1i couples recorded by online CD measurements at 263 nm had positive and negative signs, respectively.
Figure 5 shows the CD spectra and the optical rotatory dispersion (ORD) curves of four isomers of 1 recorded in ethanol. As expected, the trend of the chiroptical properties as a function of the wavelength for each couple of enantiomers was perfectly specular. It is worth noting that imine/enamine isomers with the same absolute configuration shared the sign of the specific rotation.

2.2. Kinetics of Base-Catalyzed Imino-Enamine Isomerization

The kinetics of the base-catalyzed imine→enamine (IE) and enamine form→imine form (EI) isomerization reactions of compound 1 were determined in different solvents (methanol, ethanol, 1-propanol, ethyl acetate, acetonitrile) containing variable concentrations of TEA, selected as a basic catalyst. The solutions were incubated at different temperatures when methanol and ethanol were used.
The isomerization reactions were monitored until the thermodynamic equilibrium between the imine and enamine forms was reached.
The equilibrium constants (Keq), related to the process IE, were calculated according to the following equation:
Keq = kIE/kEI = [E]eq/[I]eq
where [I]eq and [E]eq are the concentrations of imine (I) and enamine (E) forms at equilibrium, respectively, while kIE and kEI are the pseudo-first-order kinetic constants for the IE and EI reactions, respectively. The sums of the rate constants for the forward and backward isomerization reactions (ksum) were calculated according to Equation (2):
ln ([I]0 − [I]eq)/([I]t − [I]eq) = − (kEI + kIE) × t = − (ksum) × t
where [I]0, [I]eq and [I]t are the concentrations of imine form (I) at time zero, equilibrium and time t, respectively. Plots traced according to Equation (2), in which the term ln ([I]0 − [I]eq)/([I]t − [I]eq) was plotted against the reaction time (Figure 6b), showed highly linear correlations (R2 > 0.990). The kinetic constants kEI and kIE, obtained by the values of Keq and ksum, as well as the corresponding half-lives (t0.5), are shown in Table 1.
The use of the 10 cm-length Chiralpak IA-3 column allowed us to set high flow rates (3.5 mL/min) and monitor very fast isomerization reactions. In the case of the base-catalyzed (S)-1i→(S)-1e reaction shown in Figure 6a, the half-life was only 7 min.
By analyzing the experimental kinetic data shown in Table 1, it is possible to identify the main factors influencing the rate of base-catalyzed isomerization. First, the nature of the solvent plays a predominant role in this type of reaction. Proceeding along the methanol/ethanol/1-propanol series of alcoholic solvents, the rate decreased sharply. To understand how strongly the nature of the alcoholic solvent affects the rate of isomerization, it is sufficient to observe the changes in the half-lives. For example, the half-life of the IE reaction in the presence of methanol/TEA (0.4%) at 35 °C was only 4 min, while in ethanol/TEA (10%) at 50 °C, it increased to 189 min. The same reaction in 1-propanol/TEA (10%) at a higher temperature than the previous ones (60 °C) was practically blocked since the concentration of the imine form did not change after 24 h.
Contrary to what was observed in ethanol and methanol, in the presence of an aprotic polar solvent such as ethyl acetate or acetonitrile, the imine form is configurationally stable and does not isomerize to the enamine form, even in the presence of high concentrations of TEA (10%) (reaction at 60 °C).
Temperature also has a marked effect on the rate of isomerization. Pseudo-first order rate constants increased with the increasing temperature in both ethanol and methanol (Table 1).
Furthermore, the concentration of the imine form (less stable in ethanol and methanol than the enamine form) at equilibrium decreased with the decreasing temperature. For example, as shown in Figure S2, the content of 1i in the isomeric mixture at equilibrium gradually decreased from 23% at 50 °C to 6% at −23 °C.
In the final step of the work, to assess the configuration stability under physiological conditions, the IE reaction was monitored in methanol solutions containing increasing percentages (5, 15, 30, 60, 80 and 100%) of 10 mM phosphate buffer at pH 7.4 and temperature of 37 °C.
Figure 7 shows the influence of the percentage of buffer on the pseudo-first order constants and the percentage of 1i at equilibrium. The addition of 15% of 10 mM buffer to the methanolic solvent resulted in a significant increase in the rate of the IE reaction; under these conditions, the maximum value of the reaction rate was reached. By increasing the concentration of buffer in methanol, a gradual decrease in the rate of isomerization was observed. In the presence of 100% phosphate buffer, the process was instead very slow, slower than that observed in pure methanol.
It is important to note that, while in the methanolic solution, the most stable form was the enamine (72%) with a half-life of 6 h; under biomimetic conditions, the equilibrium was completely shifted in favor of the imine (99% of the total), and the half-lives of 1i and 1e were 23 h and 14 min (Figure 7).

3. Materials and Methods

3.1. Materials

Methanol, ethanol, 2-propanol and acetonitrile, diethylamine and triethylamine were purchased by Sigma-Aldrich (Milan, Italy). Chiral HPLC separations were performed on the Chiralpak IA (250 mm × 4.6 mm I.D., 5 μm), Chiralpak IA-3 (100 mm × 4.6 mm I.D., 3 μm) and Chiralpak IA (250 mm × 10 mm I.D., 5 μm) columns purchased from Chiral Technologies Europe (Illkirch, France).

3.2. Chromatographic Analysis

The analytical analysis was performed by a high-performance liquid chromatography (HPLC) apparatus consisting of a Perkin-Elmer pump (LC 2000 series) (Norwalk, CT, USA), Rheodyne injector (Cotati, CA, USA), 50 μL sample loop, Jasco CD 2095 Plus UV/CD detector (Tokyo, Japan) and Perkin-Elmer LC 101 HPLC thermostat (Sunnyvale, CA, USA).
For semipreparative separation, the HPLC apparatus was similar to the previous one but with a different sample loop capacity (2000 μL) and detector (UV Waters 484, Waters Corporation, Milford, MA, USA). All data were acquired and processed by ClarityTM software DataApex (Prague, Czech Republic).

3.3. Chiroptical Analysis

The CD spectra of the enantiomers of 1i and 1e were recorded using a Jasco (Jasco, Tokyo, Japan) J-700 spectropolarimeter. The enantiomers, isolated on a semi-preparative scale, were dissolved in ethanol at a concentration of approximately 0.3 mg/mL and successively transferred to a quartz cell (0.1 cm path length) at 25 °C. The CD spectra were averaged over three instrumental scans, and the intensities are expressed as ellipticity values (mdeg).
The specific optical rotations of the enantiomers of 1i and 1e were determined using a Perkin Elmer 241 polarimeter equipped with sodium and mercury lamps. A 1 mL cell with an optical path of 10 cm was used. The system was thermostated at 20 °C using a Neslab RTE 740 cryostat.

3.4. Synthesis of Compound 1i

Solvents and reagents were employed as provided by the vendors without further purification (Sigma-Aldrich®, Milan Italy). Where mixtures of solvents are specified, the stated ratios are volume:volume. 1H and 13C NMR spectra were recorded at 400 MHz on a Bruker spectrometer using CDCl3 as the solvent at room temperature. Chemical shifts are expressed as δ units (parts per millions) relative to the solvent signal. 1H spectra are reported as follows: δH (spectrometer frequency, solvent): chemical shift/ppm (multiplicity, J-coupling constant(s), number of protons, assignment). Multiplets are abbreviated as follows: br—broad; s—singlet; d—doublet; t—triplet; q—quartet; m—multiplet. Coupling constants J are valued in Hertz (Hz). Purification on column chromatography was carried out using silica gel (high purity grade, pore size 60 Å, 230–400 mesh particle size). All the operations were monitored by TLC performed on 0.2 mm-thick silica gel-aluminium backed plates (60 F254, Merck, Lowe, NJ, USA). Visualization was carried out under ultra-violet irradiation (254 nm). Where given, systematic compound names are those generated by ChemBioDraw Ultra 12.0 following IUPAC conventions.
The synthesis and chemical characterization of compound 1i was accomplished through a multistep approach, taking advantage of our previously reported procedure (Scheme 1) [15]. Briefly, N-allyl saccharin (A) was obtained through nucleophilic substitution between saccharin and allyl bromide, while the hydroximinoyl acid chloride (N-hydroxynicotinimidoyl chloride, B) was synthesized in two steps from the corresponding benzaldehyde (Scheme 1). N-allyl saccharin (A) and the N-hydroxynicotinimidoyl chloride (B) were the final reagents to perform the 1,3-dipolar cycloaddition, leading to the title compound 1i.
Compound 1e was obtained through the base-catalyzed imino-enamine tautomerism reported above and isolated by HPLC.
2-((3-(pyridin-3-yl)-2,5-dihydroisoxazol-5-yl)methyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide (1e). Colourless oil. 1H-NMR (400 MHz, CDCl3): δ 3.96 (dd, 2J = 14.8 Hz, 3J = 7.5 Hz, 1H, CH2), 4.10 (dd, 2J = 14.8 Hz, 3J = 5.6 Hz, 1H, CH2), 4.45 (q, J = 7.2 Hz, 1H, Hisoxazoline), 6.43–6.45 (m, 1H, Hisoxazoline), 8.66–8.68 (m,1H, Ar), 7.35–7.39 (m, 1H, pyr), 7.63–7.67 (m, 1H, Ar), 7.83–7.85 (m, 1H, Ar), 7.88–7.95 (m, 1H, Ar), 7.98–7.99 (m, 1H, pyr), 8.66–8.68 (m, 1H, pyr), 8.82–8.83 (m, 1H, pyr). Anal. Calcd for C16H13N3O4S: C, 55.97; H, 3.82; N, 12.24. Found: C, 55.94; H, 3.84; N, 12.25.

3.5. Absolute Configuration Assignment

The assignment of the absolute configuration to the enantiomers of 1i and 1e collected at the semipreparative level was determined empirically by circular dichroism correlation, using the enantiomers of an analog of 1i bearing the phenyl ring instead of the pyridyl ring as references to known stereochemistry [14]. As shown in Figure 5, the enantiomers of the chiral compounds exhibited intense and very similar electronic CD spectra in the ethanol solution [14]. This indicates that the first eluted enantiomers of the imine and enamine forms of 1 had an R configuration, and the more retained enantiomers had an S configuration.

4. Conclusions

In summary, the selectivity of chiral stationary phases containing amylose (3,5-dimethylphenylcarbamate) as a selector made it possible to separate the enantiomers of the imine and enamine forms of 1 in a single-run. The enantio- and tautomer-selective HPLC method was exploited to investigate the influence of various factors (e.g., temperature, type of reaction solvent, concentration of basic catalysts) on the isomeric imine/enamine ratio.
As established by off-column kinetic experiments, the isomeric interconversion of 1 was promoted by a basic catalyst and proceeded without concomitant racemization of the stereocenter C4.
Under the conditions used in the last step of the synthesis of 1 (solvent reaction: ethyl acetate/TEA, temperature: 25 °C, reaction time: 24 h) (Scheme 1), the imine-enamine conversion was blocked, and only the imine form, which was less stable than the enamine form, was present, as demonstrated by the HPLC analysis.
In other words, the reaction proceeded to produce a pair of enantiomers of the kinetically favored imine form.
Conversely, in methanol, in the presence of a basic catalyst, the thermodynamically favored enamine form was mainly obtained. Therefore, the synthesis of isoxazoline derivatives could be modulated favoring the imine or enamine form simply by switching the reaction conditions from a kinetic to a thermodynamic control and vice versa.
Under biomimetic conditions, the tautomeric equilibrium was completely shifted in favor of the imine form, which represented 99% of the isomeric mixture. Since the control of configurational integrity is a critical aspect in the design of chiral biologically active molecules, the kinetic results presented in this study can provide the chemical pathway to rationally design drug candidates based on isoxazoline scaffold with configurational stability compatible with the pharmacological time scale.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules28186518/s1, Figure S1: UV spectra of 1e and 1i; Figure S2: Effect of temperature on the %1i at equilibrium.

Author Contributions

R.C. conceived and designed the experiments; D.S. (Daniele Sadutto) and R.C. performed the HPLC and chiroptical analysis; P.G., D.S. (Daniela Secci) and S.C. synthesized and characterized the compound 1; D.S. (Daniele Sadutto) and R.C. analyzed the data; R.C. wrote the paper; D.S. (Daniele Sadutto), R.C., P.G., D.S. (Daniela Secci) and S.C. edited the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data sharing not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Not applicable.

References

  1. Cavazzini, A.; Pasti, L.; Massi, A.; Marchetti, N.; Dondi, F. Recent applications in chiral high performance liquid chromatography: A review. Anal. Chim. Acta 2011, 706, 205–222. [Google Scholar] [CrossRef] [PubMed]
  2. Lämmerhofer, M. Chiral recognition by enantioselective liquid chromatography: Mechanisms and modern chiral stationary phases. J. Chromatogr. A 2010, 1217, 814–856. [Google Scholar] [CrossRef] [PubMed]
  3. Wolf, C. Stereolabile chiral compounds: Analysis by dynamic chromatography and stopped-flow methods. Chem. Soc. Rev. 2005, 34, 595–608. [Google Scholar] [CrossRef] [PubMed]
  4. Cirilli, R.; Ferretti, R.; La Torre, F.; Secci, D.; Bolasco, A.; Carradori, S.; Pierini, M. High-performance liquid chromatographic separation of enantiomers and diastereomers of 2-methylcyclohexanone thiosemicarbazone, and determination of absolute configuration and configurational stability. J. Chromatogr. A 2007, 1172, 160–169. [Google Scholar] [CrossRef] [PubMed]
  5. Rizzo, S.; Benincori, T.; Bonometti, V.; Cirilli, R.; Mussini, P.R.; Pierini, M.; Pilati, T.; Sannicolò, F. Steric and electronic effects on the configurational stability of residual chiral phosphorus-centered three-bladed propellers: Tris-aryl phosphanes. Chem. Eur. J. 2013, 19, 182–194. [Google Scholar] [CrossRef]
  6. Schurig, V. Peak coalescence phenomena in enantioselective chromatography. Chirality Pharmacol. Biol. Chem. Conseq. Mol. Asymmetry 1998, 10, 140–146. [Google Scholar]
  7. Trapp, O.; Schoetz, G.; Schurig, V. Determination of enantiomerization barriers by dynamic and stopped-flow chromatographic methods. Chirality 2001, 13, 403–414. [Google Scholar] [CrossRef]
  8. Trapp, O. Interconversion of stereochemically labile enantiomers (enantiomerization). Differ. Enantiomers II 2013, 341, 231–269. [Google Scholar]
  9. D’Acquarica, I.; Gasparrini, F.; Pierini, M.; Villani, C.; Zappia, G. Dynamic HPLC on chiral stationary phases: A powerful tool for the investigation of stereomutation processes. J. Sep. Sci. 2006, 29, 1508–1516. [Google Scholar] [CrossRef] [PubMed]
  10. Storch, G.; Spallek, M.J.; Rominger, F.; Trapp, O. Tautomerization-Mediated Molecular Switching Between Six-and Seven-Membered Rings Stabilized by Hydrogen Bonding. Chem. Eur. J. 2015, 21, 8939–8945. [Google Scholar] [CrossRef]
  11. Cirilli, R.; Costi, R.; Di Santo, R.; La Torre, F.; Pierini, M.; Siani, G. Perturbing effects of chiral stationary phase on enantiomerization second-order rate constants determined by enantioselective dynamic high-performance liquid chromatography: A practical tool to quantify the accessible acid and basic catalytic sites bonded on chromatographic supports. Anal. Chem. 2009, 81, 3560–3570. [Google Scholar] [PubMed]
  12. Caccamese, S.; Principato, G. Resolution of the enantiomers of tetrahydrozoline by chiral HPLC. The racemization of the enantiomers via an imine–enamine tautomerism. Tetrahedron Asymmetry 1998, 9, 2939–2945. [Google Scholar] [CrossRef]
  13. De Camp, W.H. Chiral drugs: The FDA perspective on manufacturing and control. J. Pharm. Biomed. Anal. 1993, 11, 1167–1172. [Google Scholar] [CrossRef] [PubMed]
  14. Kumar, G.; Shankar, R. 2-Isoxazolines: A synthetic and medicinal overview. ChemMedChem 2021, 16, 430–447. [Google Scholar] [CrossRef] [PubMed]
  15. D’Ascenzio, M.; Secci, D.; Carradori, S.; Zara, S.; Guglielmi, P.; Cirilli, R.; Pierini, M.; Poli, G.; Tuccinardi, T.; Angeli, A. 1, 3-Dipolar cycloaddition, HPLC enantioseparation, and docking studies of saccharin/isoxazole and saccharin/isoxazoline derivatives as selective carbonic anhydrase IX and XII inhibitors. J. Med. Chem. 2020, 63, 2470–2488. [Google Scholar] [CrossRef] [PubMed]
  16. Zhang, T.; Kientzy, C.; Franco, P.; Ohnishi, A.; Kagamihara, Y.; Kurosawa, H. Solvent versatility of immobilized 3, 5-dimethylphenylcarbamate of amylose in enantiomeric separations by HPLC. J. Chromatogr. A 2005, 1075, 65–75. [Google Scholar] [CrossRef] [PubMed]
  17. Chankvetadze, B. Recent trends in preparation, investigation and application of polysaccharide-based chiral stationary phases for separation of enantiomers in high-performance liquid chromatography. Trends Analyt. Chem. 2020, 122, 115709. [Google Scholar] [CrossRef]
  18. Ikai, T.; Okamoto, Y. Structure control of polysaccharide derivatives for efficient separation of enantiomers by chromatography. Chem. Rev. 2009, 109, 6077–6101. [Google Scholar] [CrossRef]
Figure 1. Base-catalyzed imine(1i)-enamine(1e) tautomerism mechanism of 1.
Figure 1. Base-catalyzed imine(1i)-enamine(1e) tautomerism mechanism of 1.
Molecules 28 06518 g001
Figure 2. HPLC of 1 using pure methanol (a) and methanol:DEA 100:0.6 (v/v) as mobile phases (b). Chromatographic conditions: column, Chiralpak IA (250 mm × 4.6 mm, 5 μm); column temperature: 25 °C (a) and 10, 25 and 40 °C (b); flow rate: 0.8 mL/min; detection, UV/CD at 263 nm.
Figure 2. HPLC of 1 using pure methanol (a) and methanol:DEA 100:0.6 (v/v) as mobile phases (b). Chromatographic conditions: column, Chiralpak IA (250 mm × 4.6 mm, 5 μm); column temperature: 25 °C (a) and 10, 25 and 40 °C (b); flow rate: 0.8 mL/min; detection, UV/CD at 263 nm.
Molecules 28 06518 g002
Figure 3. Base-catalyzed off-column tautomerization of rac-1 monitored by HPLC. Solvent reaction: ethanol-TEA 92:8 (v/v); temperature reaction: 60 °C. Chromatographic conditions: column, Chiralpak IA (250 mm × 4.6 mm, 5 μm); mobile phase, ethanol-ethyl acetate-DEA 100:20:0.1 (v/v/v); column temperature: 25 °C; flow rate: 0.8 mL/min; detection, UV/CD at 263 nm.
Figure 3. Base-catalyzed off-column tautomerization of rac-1 monitored by HPLC. Solvent reaction: ethanol-TEA 92:8 (v/v); temperature reaction: 60 °C. Chromatographic conditions: column, Chiralpak IA (250 mm × 4.6 mm, 5 μm); mobile phase, ethanol-ethyl acetate-DEA 100:20:0.1 (v/v/v); column temperature: 25 °C; flow rate: 0.8 mL/min; detection, UV/CD at 263 nm.
Molecules 28 06518 g003
Figure 4. Base-catalyzed off-column tautomerization of (S)-1i monitored by HPLC. Solvent reaction: ethanol-TEA 92:8 (v/v); temperature reaction: 60 °C. Chromatographic conditions: column, Chiralpak IA (250 mm × 4.6 mm, 5 μm); mobile phase, ethanol-ethyl acetate-DEA 100:20:0.1 (v/v/v); column temperature: 25 °C; flow rate: 0.8 mL/min; detection, UV/CD at 263 nm.
Figure 4. Base-catalyzed off-column tautomerization of (S)-1i monitored by HPLC. Solvent reaction: ethanol-TEA 92:8 (v/v); temperature reaction: 60 °C. Chromatographic conditions: column, Chiralpak IA (250 mm × 4.6 mm, 5 μm); mobile phase, ethanol-ethyl acetate-DEA 100:20:0.1 (v/v/v); column temperature: 25 °C; flow rate: 0.8 mL/min; detection, UV/CD at 263 nm.
Molecules 28 06518 g004
Figure 5. CD spectra and ORD curves of isomers (S)-1e, (R)-1e, (R)-1i, (S)-1i recorded in ethanol solution.
Figure 5. CD spectra and ORD curves of isomers (S)-1e, (R)-1e, (R)-1i, (S)-1i recorded in ethanol solution.
Molecules 28 06518 g005
Figure 6. (a) Base-catalyzed off-column tautomerization of (S)-1i monitored by HPLC. Solvent reaction: methanol-TEA 100:0.4 (v/v); temperature reaction: 30 °C. Chromatographic conditions: column, Chiralpak IA-3 (100 mm × 4.6 mm, 3 μm); mobile phase, n-hexane-ethanol-ethyl acetate-DEA 50:50:20:0.1 (v/v/v/v); column temperature: 25 °C; flow rate: 3.5 mL/min; detection, UV/CD at 263 nm. (b) time-dependent decay of the (S)-1i form.
Figure 6. (a) Base-catalyzed off-column tautomerization of (S)-1i monitored by HPLC. Solvent reaction: methanol-TEA 100:0.4 (v/v); temperature reaction: 30 °C. Chromatographic conditions: column, Chiralpak IA-3 (100 mm × 4.6 mm, 3 μm); mobile phase, n-hexane-ethanol-ethyl acetate-DEA 50:50:20:0.1 (v/v/v/v); column temperature: 25 °C; flow rate: 3.5 mL/min; detection, UV/CD at 263 nm. (b) time-dependent decay of the (S)-1i form.
Molecules 28 06518 g006
Figure 7. Effect of pH 7.4 phosphate buffer on the rate of the 1i1e reaction and % 1ieq.
Figure 7. Effect of pH 7.4 phosphate buffer on the rate of the 1i1e reaction and % 1ieq.
Molecules 28 06518 g007
Scheme 1. Synthesis of the compound 1i.
Scheme 1. Synthesis of the compound 1i.
Molecules 28 06518 sch001
Table 1. Experimental kinetic constants (kobs) and half-life times (t0.5) of the pseudo-first-order isomerization imine/enamine process of 1 determined by the off-column HPLC method.
Table 1. Experimental kinetic constants (kobs) and half-life times (t0.5) of the pseudo-first-order isomerization imine/enamine process of 1 determined by the off-column HPLC method.
Reaction SolventT(°C)k(IE)(s−1)k(EI)(s−1)t0.5(IE)(min)t0.5(EI)(min)
Methanol/TEA (0.1%)201.64 × 10−42.89 × 10−570400
Methanol/TEA (0.1%)251.69 × 10−43.18 × 10−568363
Methanol/TEA (0.1%)303.36 × 10−47.07 × 10−534163
Methanol/TEA (0.1%)351.20 × 10−32.65 × 10−41044
Methanol/TEA (0.2%)202.66 × 10−44.70 × 10−543246
Methanol/TEA (0.2%)253.64 × 10−46.84 × 10−532169
Methanol/TEA (0.2%)308.06 × 10−41.65 × 10−41470
Methanol/TEA (0.2%)351.79 × 10−34.23 × 10−4627
Methanol/TEA (0.4%)204.39 × 10−47.75 × 10−526149
Methanol/TEA (0.4%)256.81 × 10−41.09 × 10−417106
Methanol/TEA (0.4%)301.65 × 10−33.37 × 10−4734
Methanol/TEA (0.4%)352.86 × 10−36.75 × 10−4417
Ethanol/TEA (10%)506.1 × 10−53.0 × 10−5189391
Ethanol/TEA (10%)558.6 × 10−54.6 × 10−5135250
Ethanol/TEA (10%)609.5 × 10−55.0 × 10−5122232
Ethanol/TEA (10%)651.3 × 10−58.2 × 10−587141
Ethanol/TEA (4%)606.4 × 10−53.4 × 10−5179340
Ethanol/TEA (6%)608.0 × 10−54.2 × 10−5145275
Ethanol/TEA (8%)608.8 × 10−54.6 × 10−5132250
1-Propanol/TEA (10%)60The isomeric ratio remained unchanged within 24 h
Ethyl acetate/TEA (10%)60The isomeric ratio remained unchanged within 24 h
Acetonitrile/TEA (10%)60The isomeric ratio remained unchanged within 24 h
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Sadutto, D.; Guglielmi, P.; Carradori, S.; Secci, D.; Cirilli, R. Kinetic Study on the Base-Catalyzed Imine-Enamine Tautomerism of a Chiral Biologically Active Isoxazoline Derivative by HPLC on Amylose Tris(3,5-dimethylphenylcarbamate) Chiral Stationary Phase. Molecules 2023, 28, 6518. https://doi.org/10.3390/molecules28186518

AMA Style

Sadutto D, Guglielmi P, Carradori S, Secci D, Cirilli R. Kinetic Study on the Base-Catalyzed Imine-Enamine Tautomerism of a Chiral Biologically Active Isoxazoline Derivative by HPLC on Amylose Tris(3,5-dimethylphenylcarbamate) Chiral Stationary Phase. Molecules. 2023; 28(18):6518. https://doi.org/10.3390/molecules28186518

Chicago/Turabian Style

Sadutto, Daniele, Paolo Guglielmi, Simone Carradori, Daniela Secci, and Roberto Cirilli. 2023. "Kinetic Study on the Base-Catalyzed Imine-Enamine Tautomerism of a Chiral Biologically Active Isoxazoline Derivative by HPLC on Amylose Tris(3,5-dimethylphenylcarbamate) Chiral Stationary Phase" Molecules 28, no. 18: 6518. https://doi.org/10.3390/molecules28186518

APA Style

Sadutto, D., Guglielmi, P., Carradori, S., Secci, D., & Cirilli, R. (2023). Kinetic Study on the Base-Catalyzed Imine-Enamine Tautomerism of a Chiral Biologically Active Isoxazoline Derivative by HPLC on Amylose Tris(3,5-dimethylphenylcarbamate) Chiral Stationary Phase. Molecules, 28(18), 6518. https://doi.org/10.3390/molecules28186518

Article Metrics

Back to TopTop